EP2370467
CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXC D3, IGF-1RXCD3 OR FAPALPHA XCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.10.2009EP published:
7.9.2016EP application number:
09740078.2
EPO information:
European Patent Register
Max expiry date:
30.9.2029
Title:
CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXC D3, IGF-1RXCD3 OR FAPALPHA XCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
Timeline
Today
1.10.2009EP application
7.9.2016EP Publication
Owner
Name:
Amgen Research (Munich) GmbHAddress:
Staffelseestrasse 2, 81477, München, DE
Inventor
Name:
KUFER, PeterAddress:
Munich, DE
Name:
RAUM, TobiasAddress:
Munich, DE
Name:
KISCHEL, RomanAddress:
Munich, DE
Name:
LUTTERBÜSE, RalfAddress:
Munich, DE
Name:
HOFFMANN, PatrickAddress:
Munich, DE
Name:
RAU, DorisAddress:
Munich, DE
Name:
KLINGER, MatthiasAddress:
Munich, DE
Name:
MANGOLD, SusanneAddress:
Munich, DE
Name:
BLÜMEL, ClaudiaAddress:
Munich, DE
Priority
Number:
101850 PDate:
1.10.2008Country:
US
Number:
101853 PDate:
1.10.2008Country:
US
Number:
101846 PDate:
1.10.2008Country:
US
Number:
101844 PDate:
1.10.2008Country:
US
Number:
101927 PDate:
1.10.2008Country:
US
Number:
101921 PDate:
1.10.2008Country:
US
Number:
101933 PDate:
1.10.2008Country:
US
Classification
Categories:
C07K 16/28, C07K 16/22, C07K 16/30, C07K 16/40